Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2025Advances in Clinical MedicineOpen Access

Serum TNC (OR 1.330) and NHR (OR 2.097) were identified as independent risk factors for moderate-to-severe coronary artery stenosis, with their combination yielding a predictive AUC of 0.852.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

To examine the relationship and combined predictive value of serum Tenascin-C, the neutrophil to high-density lipoprotein cholesterol ratio, and the severity of coronary artery lesions in patients with coronary heart disease.

Do serum TNC levels and NHR ratio correlate with and predict the severity of coronary artery lesions in patients undergoing coronary angiography?

Population

119 patients with coronary heart disease and 69 negative controls undergoing coronary angiography

Comparison

Coronary heart disease vs negative controls and across lesion severity groups

Key result

Serum TNC (OR 1.330) and NHR (OR 2.097) were identified as independent risk factors for moderate-to-severe coronary artery stenosis, with their combination yielding a predictive AUC of 0.852.

Authors

海高海新 高

Discussion

Loading...

Member takes

Overview

TNC and NHR may aid CAD severity assessment; observational data leave open prospective validation before clinical adoption.

Study Design

Type

Cross-Sectional (n=188)

Multicenter

No

Structured PICO

Do serum TNC levels and NHR ratio correlate with and predict the severity of coronary artery lesions in patients undergoing coronary angiography?

P
Population
188 adults undergoing their first coronary angiography, including 119 with confirmed coronary heart disease and 69 controls, evaluated for the correlation between serum TNC, NHR, and coronary stenosis severity.
C
Comparator
Non-CHD patients with negative coronary angiography (n=69)
O
Outcome
Correlation between serum TNC levels, NHR ratio, and severity of coronary artery lesions (assessed by Gensini score), and their predictive value for moderate-to-severe stenosissurrogate

Main Result

Odds Ratio: 2.097 (95% CI 1.42–3.095)

p-value: p=<0.001

Serum TNC levels and the NHR ratio are significantly elevated in patients with coronary heart disease and their combination offers strong predictive value for moderate-to-severe coronary artery stenosis.

Limitations

  • Single-center cross-sectional study with a small sample size, which may introduce bias
  • Unable to establish a causal relationship between TNC, NHR, and coronary heart disease
  • Single-center cross-sectional study
  • Small sample size
  • Potential bias
  • Unable to explore causal relationship

Cite This Study

海新 高 (2025) conducted a cross-sectional in Coronary Heart Disease (n=188). Serum TNC levels and NHR ratio vs. Lower levels / Non-CHD patients was evaluated on Moderate-to-severe coronary artery stenosis (NHR ratio) (OR 2.097, 95% CI 1.420-3.095, p=<0.001). Serum TNC (OR 1.330) and NHR (OR 2.097) were identified as independent risk factors for moderate-to-severe coronary artery stenosis, with their combination yielding a predictive AUC of 0.852.

synapsesocial.com/papers/6a903de2d30595a0c64dcb95https://doi.org/10.12677/acm.2025.1561831
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1RELATIONSHIP BETWEEN NEUTROPHILTO HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND THE SEVERITY OF CORONARY STENOSIS IN PATIENT WITH CORONARY ARTERY DISEASE2024
  2. 2EXPRESS: Investigation into the Significance of CCTA-FFR, TyG Index, and NLR in Assessing the Stenosis Degree of Coronary Atherosclerosis2026
  3. 3Exploring the relationship between NHHR and the degree of coronary artery stenosis in patients with acute coronary syndromes2025 · 5 citations
  4. 4Correlation of neutrophil/lymphocyte, monocyte/lymphocyte, and CRP/ALB ratios with the extent of coronary artery lesions and their predictive value2026 · 1 citations
  5. 5Related risk analysis of serum TRF and LGP2 and the cardiac function in patients with coronary heart disease2026